Bionomics Balance Sheet Health

Financial Health criteria checks 4/6

Bionomics has a total shareholder equity of $17.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $27.6M and $10.2M respectively.

Key information

0%

Debt to equity ratio

US$0

Debt

Interest coverage ration/a
CashUS$12.61m
EquityUS$17.49m
Total liabilitiesUS$10.16m
Total assetsUS$27.65m

Recent financial health updates

We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Sep 29
We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Recent updates

We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Sep 29
We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Bionomics receives R&D tax incentive refund for FY22 of A$4.6M

Oct 18

Financial Position Analysis

Short Term Liabilities: BNOX's short term assets ($13.2M) exceed its short term liabilities ($3.8M).

Long Term Liabilities: BNOX's short term assets ($13.2M) exceed its long term liabilities ($6.3M).


Debt to Equity History and Analysis

Debt Level: BNOX is debt free.

Reducing Debt: BNOX has no debt compared to 5 years ago when its debt to equity ratio was 110.9%.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: BNOX has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: BNOX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.6% each year


Discover healthy companies